Hemoglobinopathies: Clinical manifestations, diagnosis, and treatment;Hämoglobinopathien: Klinische erscheinungsbilder, diagnostische und therapeutische hinweise

Deutsches Arzteblatt

Volumn 108, Issue 31-32, 2011, Pages 532-540

  Kohne, Elisabeth ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; HEMOGLOBIN C; HEMOGLOBIN E; HEMOGLOBIN S; HEMOGLOBIN VARIANT; HYDROXYUREA;

ALPHA THALASSEMIA; BETA THALASSEMIA; BLOOD TRANSFUSION; CLINICAL FEATURE; DISEASE SEVERITY; GERMANY; HEMOGLOBINOPATHY; HUMAN; IRON CHELATION; IRON DEFICIENCY ANEMIA; LIFESPAN; PALLIATIVE THERAPY; PATIENT CARE; REVIEW; STEM CELL TRANSPLANTATION; SURVIVAL; TREATMENT INDICATION;

ALPHA-THALASSEMIA; BETA-THALASSEMIA; BLOOD TRANSFUSION; CROSS-SECTIONAL STUDIES; EMIGRATION AND IMMIGRATION; GERMANY; HEMOGLOBIN C; HEMOGLOBIN E; HEMOGLOBIN, SICKLE; HEMOGLOBINOPATHIES; HETEROZYGOTE DETECTION; HUMANS; IRON CHELATING AGENTS; PALLIATIVE CARE; STEM CELL TRANSPLANTATION;

EID: 80053612451     PISSN: 00121207     EISSN: 01722107     Source Type: Journal    
DOI: 10.3238/arztebl.2011.0532     Document Type: Review

References (26)

1. Weatherall DJ: Hemoglobinopathies worldwide: Present and future. Curr Mol Med 2008; 8: 592-9.
2. Kleihauer E, Kohne E, Kulozik AE: Anomale Hämoglobine und Thalassämie-Syndrome. Grundlagen und Klinik. Landsberg: Ecomed Verlagsgesellschaft 1996.
3. Steinberg MH, Forget BG, et al.: (eds.): Disorders of hemoglobin: genetics, pathophysiology and clinical management. Cambridge University Press 2001.
4. Kulozik AE: Hemoglobinopathies are on the increase [Hä moglobinopathien nehmen zu]. Dtsch Arztebl Int 2010; 107: 63-4.
5. th Edition. Oxford: Blackwell Science Ltd 2001.
6. Kohne E, Kleihauer E: Hemoglobinopathies in Germany - a longitudinal study over four decades [Hämoglobinopathien - eine Langzeitstudie über vier Jahrzehnte]. Dtsch Arztebl Int 2010; 107: 65-72.
7. Cario H, Stahnke K, Sander S, Kohne E: Epidemiological situation and treatment of patients with thalassemia major in Germany: results of the German multicenter-thalassemia study. Ann Hematol 2000; 79: 7-12. (Pubitemid 30157744)
8. Dickerhoff R, Von Rücker A, Maschmeyer G, Heimpel H: Probleme erwachsener Sichelzellpatienten in Deutschland. Dtsch med Wschr 2009; 134: 1179-84.
9. th edition. Frankfurt: TH-Books Verlagsgesellschaft 2011.
10. Weatherall DJ, Clegg JB, Higgs DR, Wood WG: The hemoglobinopathies. In: Scriver CR, Beauder AL, Sly WS, Valle D, Graw-Hill Mc. The metabolic basis of inherited disease. 8th edition. New York 2000.
11. Herklotz R, Risch L, Huber AR: Hämoglobinopathien - Klinik und Diagnostik von Thalassämien und anomalen Hämoglobinen. Therapeutische Umschau 2006; 1: 35-46. (Pubitemid 43099162)
12. Higgs DR, Weatherall DJ: The Alpha Thalassaemias. Cell Mol Life Sci 2009; 66: 1154-62.
13. Olivieri NF: The β-Thalassemias. N Engl J Med 1999; 341: 99-109.
14. Steinberg MH: Sickle cell anemia, the first molecular disease: Overview of molecular etiology, pathophysiology, and therapeutic approaches. Sci world J 2008; 8: 1295-324.
15. Ohba Y: Unstable hemoglobins. Hemoglobin 1990; 14: 353.
16. Petrides PE, Beykirch MK, Kohne E: The high oxygen-affinity Hemoglobin Johnstown 109 (G11) ValLeu in a German kindred with an elevated erythrocyte hemoglobin conten: Potential interaction with HFE mutation. Blood Cells Mol Dis 2008; 40(2): 180-2. (Pubitemid 351221384)
17. Wajcman H, Galactéros F: Hemoglobins with high oxygen affinity leading to erythrocytosis, new variants and new concepts. Hemoglobin 2005; 29: 91-106. (Pubitemid 40686665)
18. Dickerhoff R: Sichelzellkrankheit. In: Leitlinien Kinderheilkunde und Jugendmedizin. I 1 2006; 1-7.
19. Kulozik AE: β-Thalassämie: Bewährtes und Neues in der Diagnostik und Therapie. Mschr Kinderheil 1996; 144: 850-62.
20. Cario H, Kohne E: β-Thalassämie, a-Thalassämie. In: Leitlinien Kinderheilkunde und Jugendmedizin. I 2a 2006; 1-11.
21. I 2b 2006; 1-3.
22. Storb RF, Lucarelli G, McSweeney PA, Childs RW: Hematopoietic cell transplantation for benign hematological disorders and solid tumors. Hematol (Am Soc Hematol Educ Program) 2003; 372-97.
23. Gattermann N: The treatment of secondary hemochromatosis [Therapie der sekundären Hämochromatose]. Dtsch Arztbl Int 2009; 106: 499-504.
24. Cario H, Janka-Schaub G, et al.: Recent developments in iron chelation therapy. Klin Päd 2007; 219: 158-65. (Pubitemid 46983779)
25. Taher A, Isma'eel H, Cappellini MD: Thalassemia intermedia: revisited. Blood Cells Mol Dis 2006; 37: 12-20. (Pubitemid 44062361)
26. Sickle Cell Society, London: Standards for the clinical care of adults with sickle cell disease in the UK 2008. www.sicklecellsociety.org.